Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-24-001269

CEO sold 3,732 shares at $29.96 ($111,811)

  • CEO acquired 9,528 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DAVIS STEPHEN CEO 2024-01-06 Option exercise +9,528 100,253 D
DAVIS STEPHEN CEO 2024-01-08 Sale −3,732 $29.96 $111,811 96,521 D
Derivatives
DAVIS STEPHEN CEO 2024-01-06 Option exercise · Restricted Stock Units −9,528 0 D
Open-market sales · 3,732 sh · avg $29.96 · $111,811
Loading xslF345X05/doc4.xml…